GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » EV-to-EBITDA

Beijing Tiantan Biological Products (SHSE:600161) EV-to-EBITDA : 22.58 (As of May. 18, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Beijing Tiantan Biological Products EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Beijing Tiantan Biological Products's enterprise value is ¥42,585 Mil. Beijing Tiantan Biological Products's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,886 Mil. Therefore, Beijing Tiantan Biological Products's EV-to-EBITDA for today is 22.58.

The historical rank and industry rank for Beijing Tiantan Biological Products's EV-to-EBITDA or its related term are showing as below:

SHSE:600161' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.65   Med: 27.39   Max: 95.27
Current: 22.58

During the past 13 years, the highest EV-to-EBITDA of Beijing Tiantan Biological Products was 95.27. The lowest was 9.65. And the median was 27.39.

SHSE:600161's EV-to-EBITDA is ranked worse than
71.43% of 455 companies
in the Biotechnology industry
Industry Median: 10.35 vs SHSE:600161: 22.58

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-18), Beijing Tiantan Biological Products's stock price is ¥28.70. Beijing Tiantan Biological Products's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.700. Therefore, Beijing Tiantan Biological Products's PE Ratio for today is 41.00.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Beijing Tiantan Biological Products EV-to-EBITDA Historical Data

The historical data trend for Beijing Tiantan Biological Products's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tiantan Biological Products EV-to-EBITDA Chart

Beijing Tiantan Biological Products Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.12 42.66 27.23 23.85 23.86

Beijing Tiantan Biological Products Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.75 25.32 21.22 23.86 22.73

Competitive Comparison of Beijing Tiantan Biological Products's EV-to-EBITDA

For the Biotechnology subindustry, Beijing Tiantan Biological Products's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Tiantan Biological Products's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Tiantan Biological Products's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Beijing Tiantan Biological Products's EV-to-EBITDA falls into.



Beijing Tiantan Biological Products EV-to-EBITDA Calculation

Beijing Tiantan Biological Products's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=42585.465/1886.129
=22.58

Beijing Tiantan Biological Products's current Enterprise Value is ¥42,585 Mil.
Beijing Tiantan Biological Products's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,886 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Tiantan Biological Products  (SHSE:600161) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Beijing Tiantan Biological Products's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=28.70/0.700
=41.00

Beijing Tiantan Biological Products's share price for today is ¥28.70.
Beijing Tiantan Biological Products's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.700.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Beijing Tiantan Biological Products EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Beijing Tiantan Biological Products's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Tiantan Biological Products (SHSE:600161) Business Description

Traded in Other Exchanges
N/A
Address
No. 4 Sanjianfang South Li, Zhongdan Center, Beijing, CHN, 100024
Beijing Tiantan Biological Products Corp Ltd is a China-based company engaged in the research and development, manufacturing, sales and consulting services for blood products. The company's blood products include Shanghai Blood Human Albumin, Shanghai blood system intravenous injection of human immunoglobulin, Guizhou blood human albumin, Rongsheng human albumin, Guizhou blood system static injection immunoglobulin, Rongsheng tetanus human immunoglobulin and others.

Beijing Tiantan Biological Products (SHSE:600161) Headlines

No Headlines